natgillin/translations-raw huggingface dataset:
painful or absence of menstrual periods sudden death associated with heart disease.
boleča menstruacija ali izostanek menstruacije nenadna smrt, ki je posledica bolezni srca.
painful or difficult urination
boleče ali oteženo uriniranje
painful or difficult urination,
bolečine ali težave z odvajanjem seča,
painful or difficult urination,
bolečine ali težave z odvajanjem urina,
painful or difficult urination, urinary frequency, the presence of excess protein in the urine, painful menstruation,
bolečine ali težave pri uriniranju, pogosto uriniranje, prisotnost čezmerne količine beljakovin v urinu, boleče menstruacije,
painful or difficulty urinating
bolečina ali težave pri uriniranju,
painful or dry mouth, painful tongue, mouth sores (stomatitis and/or mucosal inflammation)
boleča ali suha usta, boleč jezik, sor v ustih (stomatitis in/ali vnetje sluznice)
painful or frequent urination
boleče ali pogosto uriniranje
Painful or swollen tummy (abdomen)
bolečine ali napihnjenost trebuha
painful periods (dysmenorrhoea), menstrual disorder, heavy uterine bleeding (metrorrhagia) especially between menstrual periods, impotence injection site reaction (including redness, swelling, discolouration, inflammation, pain, allergic reaction, see section 2 “Warnings and precautions”), skin breakdown and tissue damage (necrosis) at injection site (see section 2 “Warnings and precautions”) flu-like symptoms, fever, pain, chest pain, accumulation of fluid in arm, leg or face (peripheral oedema), lack/loss of strength (asthenia), chills, sweating, general feeling of being unwell.
boleče mesečne krvavitve (dismenoreja), menstruacijske motnje, močne maternične krvavitve (metroragija), zlasti v vmesnem obdobju med dvema menstruacijama, impotenca reakcije na mestu injiciranja (vključno z rdečico, otekanjem, obarvanjem, vnetjem, bolečino, alergijskimi reakcijami, glejte poglavje 2 Opozorila in previdnostni ukrepi), razpadanje kože in odmiranje tkiva (nekroza) na mestu injiciranja (glejte poglavje 2 Opozorila in previdnostni ukrepi) gripi podobni simptomi, zvišana telesna temperatura, bolečine, bolečine v prsih, kopičenje tekočine v rokah, nogah ali obrazu (periferni edem), pomanjkanje/izguba moči (astenija), mrzlica, potenje, splošno slabo počutje
painful periods, pelvic pain, breast tenderness
boleče menstruacije, bolečine v medenici, občutljive dojke
Painful red bumps on the skin
boleče rdeče bule na koži;
Painful redness and/or swelling of the eye.
Boleča pordelost in/ali oteklost oči.
painful skin
boleča koža
painful skin lesions of the arms and legs and face (erythema nodosum)
boleče spremembe na koži rok, nog in obraza (nodozni eritem)
painful skin rash with blisters (possible symptoms of shingles (herpes zoster)) (common)
boleč kožni izpuščaj z mehurčki (kar so lahko simptomi pasovca (herpes zoster)) (pogosti)
Painful skin rash with blisters (shingles, zona)
boleč kožni izpuščaj s pojavom mehurčkov (herpes zoster, pasovec)
Painful skin ulceration (pyoderma gangrenosum).
boleče razjede na koži (gangrenozna pioderma)
painful sores in the mouth
boleče razjede v ustih
Painful stiff neck (torticollis)
Boleč, trd vrat (tortikolis)
Painful swallowing
bolečine pri požiranju,
Painful swallowing;
bolečine pri požiranju,
painful swollen joints caused by uric acid (food breakdown product) (gout);
boleča oteklost sklepov zaradi sečne kisline (razgradnega produkta hrane) (protin),
painful swollen joints caused by uric acid (gout)
boleča oteklina sklepov zaradi sečne kisline (protin)
painful tongue, polyps inside your mouth, mouth ulcers, retching
boleč jezik, polipi v ustih, razjede v ustih, siljenje na bruhanje
Painful urination
boleče uriniranje
painful urination, frequent urination
boleče uriniranje, pogosto uriniranje
Painful urination, frequent urination, blood in the urine, inability to hold your urine
boleče uriniranje, pogosto uriniranje, kri v urinu, nezmožnost zadrževanja urina
painful urination, frequent urination, blood in the urine, inability to hold your urine,
boleče uriniranje, pogosto uriniranje, kri v urinu, nezmožnost zadrževanja urina,
painful urination, frequent urination;
boleče uriniranje, pogosto uriniranje;
Painful urination.
boleče uriniranje
Painful, numb and/or tingling feeling in fingers and toes (peripheral neuropathy)
boleč, otrpel in/ali ščemeč občutek v prstih rok in nog (periferna nevropatija);
painful, sore or inflamed throat or nose
boleče ali vneto žrelo ali nos,
painful/increased urination
boleče/pogostejše uriniranje
painkillers (such as tramadol and pethidine) used for pain relief triptans (such as sumatriptan and zolmitripitan) used for treating migraine
zdravila proti bolečinam (kot sta tramadol in petidin) uporabljamo za ublažitev bolečine, triptane (kot sta sumatriptan in zolmitriptan) uporabljamo za zdravljenje migrene.
painless blurring of vision which can progress to loss of vision
neboleča zameglitev vida, ki lahko napreduje v izgubo vida;
painless blurring of vision which can progress to loss of vision.
zameglitev vida brez bolečine, ki lahko napreduje v izgubo vida
Painless swellings occur occasionally with a size up to 2 cm in sheep and up to 4.5 cm in cattle after a double dose.
Občasno se po dvojnemu odmerku pojavijo neboleče bule, velikosti do 2 cm pri ovcah in do 4,5 cm pri govedu.
Painless swellings occur occasionally with a size up to 2 cm in sheep and up to 4.5 cm in cattle after administration of a double dose.
Občasno se po dvojnemu odmerku pojavijo neboleče bule, velikosti do 2 cm pri ovcah in do 4,5 cm pri govedu.
Painless ulcers, erythema, or mild soreness.
Neboleče razjede, eritem ali blage bolečine.
pains in muscles or joints collapse or blackout.
bolečine v mišicah ali sklepih, kolaps ali izgubo zavesti.
pains or difficulties in passing urine (very rare), blood in the urine, protein in the urine
bolečine ali težave pri uriniranju (zelo redko); kri v urinu; beljakovine v urinu
Pairwise comparison p-values: * = p < 0.05 for comparisons of etanercept vs.methotrexate, † = p < 0.05 for comparisons of etanercept + methotrexate vs. methotrexate and Φ = p < 0.05 for comparisons of etanercept + methotrexate vs. etanercept.
Vrednosti p za primerjavo po parih: * = p < 0,05 za primerjavo etanercepta z metotreksatom, † = p < 0,05 za primerjavo kombinacije etanercepta + metotreksata z metotreksatom in Φ = p < 0,05 za primerjavo kombinacije etanercepta + metotreksata z etanerceptom.
Pairwise comparison p-values: † = p < 0.05 for comparisons of Enbrel + methotrexate vs methotrexate  and  = p < 0.05 for comparisons of Enbrel + methotrexate vs Enbrel
Vrednosti p za primerjavo po parih: † = p < 0,05 za primerjavo kombinacije zdravila Enbrel + metotreksat z metotreksatom in  = p < 0,05 za primerjavo kombinacije zdravila Enbrel +  metotreksat z zdravilom Enbrel.
Palackého trída 163a 612 00 Brno CZECH REPUBLIC
Palackého trída 163a 612 00 Brno
pale areas on the skin
bledi predeli na koži
Pale blue to pastel blue, pentagonal film-coated tablets with imprint on one side (‘14’) and engraved with a corporate logo on the other side.
Bledo modre do pastelno modre, petkotne filmsko obložene tablete z napisom (‘14’) na eni strani in vtisnjenim logotipom na drugi strani.
Pale blue/white capsules, size 0, 21.7 mm, marked “REV 15 mg”.
Svetlomodre/bele kapsule velikosti 0, 21,7 mm, z oznako "REV 15 mg".
Pale milky coloured homogeneous suspension.
Bledo mlečno obarvana homogena suspenzija.
Pale opalescent liquid prior to reconstitution.
Svetla opalescentna tekočina pred rekonstitucijo.
Pale or greyish skin colour
bledo ali sivkasto barvo kože
Pale orange opaque cap and body, capsule size 1 (19.4 mm x 6.9 mm) filled with white to nearly white coloured powder.
Neprozorna pokrovček in telo svetlo oranžne barve, velikost kapsule 1 (19,4 mm x 6,9 mm), napolnjena s praškom bele do belkaste barve.
Pale orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 2 and an “R” on the other side.
Svetloranžne, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama " 2'' in "R".
Pale peach, round (approximately 8.7 mm in diameter), biconvex, film coated tablets with both “A/P” and “12.5/30” printed in red ink on one side.
Okrogle (premer približno 8,7 mm), bikonveksne, filmsko obložene tablete svetle breskove barve z odtisnjenima rdečima oznakama “A/P” in “12.5/30” na eni strani.
Pale pink film-coated tablets marked "gsk" on one side and "2/500" on the other.
Bledo rožnate filmsko obložene tablete z oznako "gsk" na eni strani in "2/500" na drugi strani.
Pale pink, biconvex, capsule shaped, film-coated tablets (tablets).
Bledo roza, izbočene, filmsko obložene tablete (tablete) v obliki kapsule.
Pale pink, biconvex, capsule shaped, film-coated tablets.
Bledo roza, izbočene, filmsko obložene tablete v obliki kapsule.
Pale pink, biconvex, oval, film-coated tablets (tablets).
Bledo roza, izbočene, ovalne, filmsko obložene tablete (tablete).
Pale pink, biconvex, oval, film-coated tablets.
Bledo roza, izbočene, ovalne, filmsko obložene tablete.
Pale purple, oval shaped film-coated tablet, debossed with "M500" on one side and plain on the other side.
Temno vijoličaste, filmsko obložene tablete ovalne oblike, z vgraviranim napisom “M500” na eni strani in brez napisa na drugi.
Pale red to grey-red, oval-oblong film-coated tablets with imprint “20” on one side and imprint “MEM” on the other side.
Bledo rdeče do sivo rdeče, ovalno podolgovate filmsko obložene tablete, z vtisnjeno številko "20" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Pale red, round (approximately 8.7 mm in diameter), biconvex, film-coated tablets with both “A/P” and “12.5/45” printed in red ink on one side.
Okrogle (premer približno 8,7 mm), bikonveksne, filmsko obložene tablete svetlo rdeče barve z odtisnjenima rdečima oznakama “A/P” in “12.5/45” na eni strani.
pale skin
bleda koža
Pale skin
bledica
pale skin colour (pallor)
bledica kože,
Pale skin, feeling tired and breathlessness and having dark urine (signs of low levels of red blood cells).
bledica, občutek utrujenosti in zasoplost in temen urin (znaki pomanjkanja rdečih krvničk),
pale skin, tiredness, breathlessness, dark-coloured urine (haemolytic anaemia)
bleda koža, utrujenost, zadihanost, temno obarvan urin (hemolitična anemija)
Pale skin, tiredness, breathlessness, dark-coloured urine (haemolytic anaemia)
bleda koža, utrujenost, zadihanost, temno obarvan urin (hemolitična anemija),
pale skin, tiredness, breathlessness, dark-coloured urine (haemolytic anaemia, abnormal breakdown of red blood cells either in the blood vessels or elsewhere in the body)
bleda koža, utrujenost, zadihanost, temno obarvan urin (hemolitična anemija, nenormalno razpadanje rdečih krvnih celic bodisi v krvnih žilah ali kje drugje v telesu)
pale skin, tiredness, or bruising, as these may indicate blood disorders caused by an imbalance in the different types of blood cells which make up blood,
bledico, utrujenost ali podplutbe, ki so lahko znak krvnih bolezni, ki jih povzroči neravnovesje različnih krvnih celic, ki sestavljajo kri,
Pale skin, tiredness, or bruising, as these may indicate blood disorders caused by an imbalance in the different types of blood cells which make up blood.
bledico, utrujenost ali podplutbe, ki so lahko znak krvnih bolezni, ki jih povzroči neravnovesje različnih krvnih celic, ki sestavljajo kri,
Pale yellow debossed with [Abbott logo] and “KC”.
Bledo rumena, z vtisnjenima oznakama [Abbottov logo] in "KC".
Pale yellow oral suspension.
Bledo rumena peroralna suspenzija.
Pale yellow solution for injection.
Bledo rumena raztopina za injiciranje.
Pale yellow suspension.
Bledorumena suspenzija.
Pale yellow to light yellow, biconvex, oval shaped, film-coated tablets, with “2.5/1000” printed on one side and “4247” printed on the other side, in blue ink.
Bledorumene do svetlo rumene, bikonveksne, filmsko obložene tablete, ovalne oblike, ki imajo z modrim črnilom na eni strani natisnjeno oznako "2.5/1000" in na drugi strani oznako "4247".
Pale yellow to off-white, clover-shape tablets, quadrisected on one side and debossed with “32” on the other side.
Bledo rumena do belkasta tableta v obliki deteljice, ki ima delilno črto za štiri dele na eni strani in vtis “32” na drugi strani.
Pale yellow to white powder and clear, colourless solvent for solution for injection. pH: 6.6 - 7.2
Bledo rumen do bel prašek in bister, brezbarven vehikel za raztopino za injiciranje. pH: 6,6-7,2
Pale yellow to yellow, film-coated, capsule shaped tablets, engraved with “80” on one side.
Svetlorumene do rumene, filmsko obložene tablete v obliki kapsule, ki imajo na eni strani vtisnjeno oznako »80«.
Pale yellow to yellow, oval shaped film-coated tablet with breaking line and engravings "1-0" on one side and "M M" on the other side
Bledo rumene do rumene, ovalne filmsko obložene tablete, z razdelilno zarezo in vtisnjeno številko "1 0" na eni strani in vtisnjeno besedo "M M" na drugi strani..
Pale yellow to yellow, oval shaped film-coated tablet with breaking line and engravings “1 0” on one side and “M M” on the other side
Bledo rumene do rumene, ovalne filmsko obložene tablete, z razdelilno zarezo in vtisnjeno številko "1 0" na eni strani in vtisnjeno besedo "M M" na drugi strani.
Pale yellow, oblong (approximately 22.3 mm long by 10.7 mm wide), biconvex, film-coated tablets with “12.5/1000” debossed on one side and “322M” debossed on the other side.
Bledo rumene, podolgovate (približno 22,3 mm dolge in 10,7 mm široke), bikonveksne, filmsko obložene tablete z vtisnjeno oznako “12.5/1000” na eni in “322M” na drugi strani.
Pale yellow, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1 and an “R” on the other side.
Svetlorumene, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama " 1" in "R".
Pale yellow-brown opaque cap and body, capsule size 4 (14.3 mm x 5.3 mm) filled with white to nearly white coloured powder.
Neprozorna pokrovček in telo blede rumenkasto-rjave barve, velikost kapsule 4 (14,3 mm x 5,3 mm), napolnjena s praškom bele do belkaste barve.
Pale yellow/white capsules, size 2, 18.0 mm, marked “REV 7.5 mg”.
Bledorumene/bele kapsule velikosti 2, 18,0 mm, z oznako "REV 7.5 mg".
Pale-yellow, single-scored, chewable tablets.
Svetlo rumene, žvečlijive tablete z zarezo na eni strani.
paleness
bledica
paleness
bledica,
paleness of the mucous membranes at the application site
bledica sluznice na mestu uporabe,
Paleness of the skin
bledica kože
Palifermin (60 micrograms/kg/day)
Palifermin (60 mikrogramov/kg/dan)
Palifermin is a human keratinocyte growth factor (KGF), produced by recombinant DNA technology in Escherichia coli.
Palifermin je humani keratinocitni rastni faktor (KGF - keratinocyte growth factor), pridobljen s tehnologijo rekombinantne DNA iz Escherichia coli.
Palifermin works in the same way as keratinocyte growth factor (KGF) which is made naturally by your body in small amounts.
Palifermin deluje enako kot keratinocitni rastni dejavnik (KGF), ki v majhni količini naravno nastaja v človeškem telesu.
Paliperidone acts mainly by blocking the receptors for the neurotransmitters dopamine and 5- hydroxytryptamine (also called serotonin).
Paliperidon deluje predvsem tako, da zavira receptorje za živčna prenašalca dopamin in 5-hidroksitriptamin (imenovan tudi serotonin).
Paliperidone binds strongly to serotonergic 5-HT2- and dopaminergic D2-receptors.
Paliperidon se močno veže na serotoninske receptorje 5-HT2 in dopaminske receptorje D2.
Paliperidone can have minor or moderate influence on the ability to drive and use machines due to potential nervous system and visual effects, such as sedation, somnolence, syncope, vision blurred (see section 4.8).
Paliperidon ima lahko blag ali zmeren vpliv na sposobnost vožnje in upravljanja s stroji zaradi možnosti pojava učinkov na živčevje in vid, kot so sedacija, somnolenca, sinkopa in zamegljen vid (glejte poglavje 4.8).
Paliperidone has not been studied in patients with severe hepatic impairment.
Pri bolnikih s hudo jetrno okvaro paliperidona niso preučevali.
Paliperidone is excreted in the breast milk to such an extent that effects on the breastfed infant are likely if therapeutic doses are administered to breastfeeding women.
Paliperidon se izloča v materino mleko v tolikšni meri, da bi verjetno vplival na dojenčka, če bi doječa mati jemala terapevtske odmerke zdravila.
Paliperidone is not expected to cause clinically important pharmacokinetic interactions with medicinal products that are metabolised by cytochrome P-450 isozymes.
Ni pričakovati, da bo paliperidon povzročil klinično pomembne farmakokinetične interakcije z zdravili, ki se presnavljajo preko citokroma P-450.
Paliperidone is not expected to cause clinically important pharmacokinetic interactions with medicinal products that are metabolised by cytochrome P450 isozymes.
Ni pričakovati, da bi paliperidon povzročil klinično pomembne farmakokinetične interakcije z zdravili, ki se presnavljajo preko citokroma P-450.
Paliperidone is not expected to cause clinically important pharmacokinetic interactions with medicines that are metabolised by cytochrome P-450 isozymes.
Ni pričakovati, da bi paliperidon povzročil klinično pomembne farmakokinetične interakcije z zdravili, ki se presnavljajo z izoencimi citokroma P-450.
Paliperidone is the active metabolite of risperidone, therefore, the adverse reaction profiles of these compounds (including both the oral and injectable formulations) are relevant to one another.
Paliperidon je aktivni presnovek risperidona, zato sta njuna profila neželenih učinkov (peroralne oblike in injekcije) odvisna eden od drugega.
Paliperidone palmitate is the palmitate ester prodrug of paliperidone.
Paliperidonijev palmitat je ester palmitinske kisline in paliperidona in je predzdravilo paliperidona.
Paliperidone should not be used in patients with creatinine clearance below 10 ml/min.
Paliperidon se ne sme uporabljati pri bolnikih z očistkom kreatinina, manjšim od 10 ml/min.
Palivizumab does not interfere with reverse transcriptase polymerase chain reaction-based assays.
Palivizumab ne moti testov, ki temeljijo na metodi obratne transkripcije in verinne reakcije s polimerazo (RT-PCR) .
Palivizumab does not interfere with reverse transcriptase polymerase chain reaction-based assays.
Palivizumab ne vpliva na teste, ki temeljijo na metodi obratne transkripcije in verižne reakcije s polimerazo (RT-PCR).
Palivizumab is a recombinant humanised monoclonal antibody produced by DNA technology in mouse myeloma host cells.
Palivizumab je rekombinantno humanizirano monoklonsko protitelo, pridobljeno z DNA tehnologijo v mielomskih celicah miši.
Palivizumab may interfere with immune-based RSV diagnostic tests, such as some antigen detection based assays.
Palivizumab lahko vpliva na nekatere imunsko osnovane RSV diagnostične teste, kot so nekateri testi, ki temeljijo na detekciji antigenov.
Palladia 10 mg film-coated tablets for Dogs Palladia 15 mg film-coated tablets for Dogs Palladia 50 mg film-coated tablets for Dogs
Palladia 10 mg filmsko obložene tablete za pse Palladia 15 mg filmsko obložene tablete za pse Palladia 50 mg filmsko obložene tablete za pse
Palladia 50 mg film-coated tablets for dogs. toceranib
Palladia 50 mg filmsko obložene tablete za pse.
Palladia 50 mg tablets for dogs. toceranib
Palladia 50 mg tablete za pse.
Palladia tablets should be given to your dog immediately after they are removed from the blister and should not be left around where they could be handled/swallowed by children.
Palladia tablete dajte vašemu psu takoj po odstranitvi iz pretisnega omota in jih ne puščajte na mestih, kjer lahko pride do stika/ zaužitja pri otrocih.
Pallagi út 13 Hungary
Pallagi út 13 Madžarska
Pallagi út 13, Hungary
4042 Debrecen,
Pallagi út 13, Hungary
4042 Debrecen, Madžarska
Pallini 15351 Attiki Greece
153 51 Pallini, Attiki Grčija
Pallini 15351, Attiki Greece
153 51 Pallini, Attiki Grčija
Pallini Attiki, 15351 Greece
153 51 Pallini, Attiki Grčija
Pallor
bledica
Pallor, flushing
bledica, pordelost
Pallor, flushing
bledica, pordelost,
Pallor, flushing
bledica, vročinski oblivi
Pallor, vein discolouration, hypotension
bledica, sprememba barve ven, hipotenzija
Palmar –plantar erythrodysaesthesia syndrome
sindrom palmarno-plantarne eritrodizestezije
Palmar- plantar erythrodysaesthesia (rash and numbness on the palms and soles) is also very common when Tyverb is taken with capecitabine.
Kadar se zdravilo Tyverb jemlje v kombinaciji s kapecitabinom, se zelo pogosto pojavi tudi palmarno-plantarna eritrodisestezija (izpuščaji in otrplost v dlaneh in podplatih).
Palmar-plantar
palmarno
Palmar-plantar erthyrodysaesthesia syndrome
Sindrom palmarno- plantarne eritrodizestezije
Palmar-plantar erythro- dysaesthesia syndrome
palmarno- plantarna eritrodisestezija
Palmar-plantar erythro- dysaesthesia syndrome
sindrom palmarno- plantarne eritrodistezije
Palmar-plantar erythro- dysaesthesia syndrome**
palmarno- plantarna eritrodisestezija
Palmar-plantar erythrodysaesthesia (hand-foot syndrome)
palmarno-plantarna eritrodisestezíja (sindrom dlani- podplatov)
Palmar-plantar erythrodysaesthesia syndrome
bolečina v kosteh
Palmar-plantar erythrodysaesthesia syndrome
Epi/CPA (75/600 mg/m
Palmar-plantar erythrodysaesthesia syndrome
indrom palmarno-plantarne eritrodisestezije
Palmar-plantar erythrodysaesthesia syndrome
indrom palmarno-plantarne eritrodizestezije
Palmar-Plantar Erythrodysaesthesia syndrome
sindrom palmarno-plantarne eritrodizestezije
Palmar-plantar erythrodysaesthesia syndrome
sindrom roke in noge
Palmar-plantar erythrodysaesthesia syndrome (dysaesthesia, erythema, oedema on the palms and soles)
hiperpigmentacija kože sindrom eritrodisestezije dlani in stopal (disestezija, eritem in edem na dlaneh in stopalih)
Palmar-plantar erythrodysaesthesia syndrome (PPES) has been observed with cabozantinib.
Pri uporabi kabozantiniba so opazili sindrom palmarno-plantarne eritrodisestezije (PPES, Palmar- plantar erythrodysaesthesia syndrome).
Palmar-plantar erythrodysaesthesia syndrome (PPES) has been observed with cabozantinib.
Pri uporabi kabozantiniba so opazili sindrom palmarno-plantarne eritrodisestezije (PPES, Palmar-plantar erythrodysaesthesia syndrome).
palmar-plantar erythrodysaesthesia syndrome, hair colour changes, rash, dry skin, alopecia, erythema
indrom palmarno- plantarne eritrodisestezije, spremenjena barva las, izpuščaj, suha koža, alopecija, eritem
Palmar-plantar erythrodysaesthesia syndrome, panniculitis (including erythema nodosum), keratosis pilaris
indrom palmarno- plantarne eritrodisestezije, panikulitis (vključno z nodoznim eritemom), pilarna keratoza
palmar-plantar erythrodysaesthesia syndrome, rash, dry skin
indrom palmarnoplantarne eritrodisestezije, izpuščaj, suha koža
Palmar-plantar erythrodysaesthesia syndrome, rash, skin hyperpigmentation, dry skin, pruritus, alopecia,
palmarno-plantarna eritrodisestezija, izpuščaj, hiperpigmentacija kože, suha koža, pruritus, alopecija
Palmar-plantar erythrodysaesthesia syndromec
indrom palmarne- plantarne eritrodisestezijec izpuščaj
Palmar-plantar erythrodysaesthiesia syndrome, alopecia
indrom palmarno- plantarne eritrodizestezije, alopecija
palmar-plantar erythrodysesthesia (PPE)
palmarno-plantarna eritrodisestezija (PPE)
Palmar-plantar erythrodysesthesia [PPE] was also common (>25%) when lapatinib was administered in combination with capecitabine.
Če je bil lapatinib uporabljen v kombinaciji s kapecitabinom, je bila pogosta (> 25 %) tudi palmarno-plantarna eritrodizestezija [PPE].
Palmar–Plantar erythrodysesthesia
Palmarno-plantarna eritrodizestezija
Palmoplantar erythrodysesthesia syndrome*, lichenoid keratosis*, lichen planus*, toxic epidermal necrolysis*, drug rash with eosinophilia and systemic symptoms (DRESS)*
indrom palmoplantarne eritrodisestezije*, lihenoidna keratoza*, lichen planus*, toksična epidermalna nekroliza*, izpuščaj zaradi zdravila z eozinofilijo in sistemskimi simptomi (DRESS - drug rash with eosinophilia and systemic symptoms)